You can view the entire document as a PDF by clicking on the PDF icon on the right or by requesting a free hard copy from the Foundation.
Quadramet® belongs to a class of drugs called radiopharmaceuticals and is used to treat bone pain that often results when cancer has spread to the bone. Quadramet® is currently approved by the United States Food and Drug Administration (FDA) to relieve pain in patients who have confirmed osteoblastic metastatic bone lesions that are evident on a bone scan.
This booklet is intended to provide a basic understanding of what you can expect from Quadramet® therapy, including:
- What Quadramet® is and how it works to treat pain from cancer that has metastasized to the bone,
- How to handle Quadramet® therapy safely,
- What side effects might be expected from Quadramet® therapy, and
- How Quadramet® may be used in combination with other therapies.